自由呼吸下连续肝动脉多期磁共振成像
前瞻性纳入40例肝脏恶性肿瘤患者,在1.5 T下行自由呼吸连续动脉多期MRI(VIBECS),另40例常规屏气VIBESTD作参考。VIBECS均可靠记录肝动脉优势期,图像质量和病灶显示优于VIBESTD,推荐时间分辨率8秒。
要点
- VIBECS自由呼吸连续采集60秒可可靠捕捉肝动脉优势期。
- 8秒时间分辨率组图像质量和病灶显示优于常规屏气VIBESTD。
- VIBESTD仅65%(26/40)动脉期 timing adequate。
核心结论
- VIBECS可在自由呼吸下以高空间和时间分辨率实现稳健的多期动脉成像,优选8秒时间分辨率,图像质量和病灶显示优于VIBESTD。
研究设计与样本
- 前瞻性研究,VIBECS组40例肝脏恶性肿瘤患者,另40例VIBESTD作参考标准;VIBECS组分2组各20例,1.5 T下行对比增强肝脏MRI。
关键影像表现/征象
- VIBECS组所有肝动脉优势期均可靠记录,A组最常见于第9时间点(静脉注射对比剂后36秒),B组于第5时间点(40秒)。
- VIBECS组图像质量、病灶显示和血管对比度良好至优秀,两组间无显著差异(P ≥ 0.2)。
- VIBECS病灶显示(P ≤ 0.006)和图像质量(B组;P < 0.001)评分显著高于VIBESTD。
- VIBECS出现重建伪影,A组显著高于B组(P = 0.001)。
- 平均动脉峰值强化A组见于第9时间点(36秒),B组见于第6时间点(48秒)。
诊断标准与关键数值
- 肝动脉优势期定义为主观图像质量最佳的时间点。
- 图像质量、病灶显示、血管对比度和伪影采用5分Likert量表(5=优秀)独立评估。
- VIBECS组A时间分辨率4秒,B组8秒,均自对比剂注射开始连续采集60秒。
- VIBESTD组 timing 仅65%(26/40) adequate。
临床应用与阅片要点
- 自由呼吸连续多期动脉采集可在不屏气条件下可靠捕捉肝动脉优势期。
- 8秒时间分辨率组图像质量更优且重建伪影少于4秒组(P = 0.001)。
- 与常规屏气VIBESTD相比,VIBECS病灶显示和图像质量评分更高。
局限性
- VIBECS出现重建伪影,A组(4秒)显著高于B组(8秒)(P = 0.001)。
- VIBESTD组动脉期 timing 仅65%(26/40) adequate。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to evaluate the feasibility of a prototype volume-interpolated breath-hold examination (VIBE) sequence using compressed sensing (VIBECS) for rapid multiphase arterial magnetic resonance imaging (MRI) at different temporal resolution during free-breathing in comparison with a conventional breath-hold approach (VIBESTD).
MATERIAL AND METHODS: A total of 40 patients with liver malignancies were prospectively included in this study and underwent contrast-enhanced liver MRI at 1.5 T to evaluate the performance of VIBECS for rapid arterial multiphase imaging. An additional 40 patients examined with a VIBESTD were included serving as standard of reference. The VIBECS study cohort was subdivided into 2 groups (each n = 20). In both groups, VIBECS was continuously acquired for 60 seconds starting with the contrast agent administration (group A, temporal resolution 4 seconds; group B, temporal resolution 8 seconds). Subsequently, the time point with the subjectively best image quality was selected and defined as hepatic arterial dominant (HAD) phase. Overall image quality, lesion conspicuity, vessel contrast, and artifacts of HAD phase were assessed by 2 radiologists independently on a 5-point Likert scale (5 = excellent) and compared with arterial phase images of VIBESTD. In addition, signal attenuation/time curves of VIBECS were plotted for each patient to quantify the hepatic arterial enhancement.
RESULTS: No patients were excluded and all HAD phases were reliably recorded in the investigated VIBECS cohort. Most commonly, HAD was observed at the ninth time point (36 seconds after intravenous contrast injection) in group A and at the fifth time point (40 seconds after intravenous contrast injection) in group B. Timing with VIBESTD was only adequate in 65% (26/40). Image quality, lesion conspicuity, and vessel contrast were good to excellent without significant differences between both VIBECS groups (P ≥ 0.2) and with significantly higher reading scores as compared with VIBESTD with respect to lesion conspicuity (P ≤ 0.006) and image quality (group B; P < 0.001). VIBECS showed reconstruction artifacts, which were significantly higher in group A (P = 0.001). Mean peak arterial enhancement was observed at the ninth time point (36 seconds) in group A and at the sixth (48 seconds) in group B.
CONCLUSION: VIBECS allows for robust multiphase arterial imaging during free-breathing at high spatial and temporal resolution (preferably 8 seconds) with improved image quality and lesion conspicuity as compared with VIBESTD.
引用
- Weiss J, Notohamiprodjo M, Taron J, et al. Continuous Hepatic Arterial Multiphase Magnetic Resonance Imaging During Free-Breathing. Invest Radiol. 2018. PMID: 29494350. doi:10.1097/RLI.0000000000000459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。